Cadherin and catenin expression in normal human bronchial epithelium and non-small cell lung cancerTobacco smoking and cancer: a brief review of recent epidemiological evidence14-kDa phosphohistidine phosphatase and its role in human lung cancer cell migration and invasionKaiso is expressed in lung cancer: its expression and localization is affected by p120ctnIncreased expression and activity of repair genes TDP1 and XPF in non-small cell lung cancerThe relationship between COPD and lung cancerFarletuzumab in lung cancerImmunotherapy in the treatment of non-small cell lung cancerInterim results in clinical trials: do we need to keep all interim randomised clinical trial results confidential?Genetic alterations defining NSCLC subtypes and their therapeutic implicationsCyclin D1 in non-small cell lung cancer: a key driver of malignant transformation.Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients.Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: the association with treatment efficacy of pemetrexed.Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu.Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer.Major partial response to crizotinib, a dual MET/ALK inhibitor, in a squamous cell lung (SCC) carcinoma patient with de novo c-MET amplification in the absence of ALK rearrangement.Response to pemetrexed rechallenge after acquired resistance of EGFR-TKI in a patient with advanced NSCLC.FGFR1 amplification in lung squamous cell carcinoma: a systematic review with meta-analysis.Favorable response to trastuzumab plus irinotecan combination therapy in two patients with HER2-positive relapsed small-cell lung cancer.I1171 missense mutation (particularly I1171N) is a common resistance mutation in ALK-positive NSCLC patients who have progressive disease while on alectinib and is sensitive to ceritinib.MET gene exon 14 deletion created using the CRISPR/Cas9 system enhances cellular growth and sensitivity to a MET inhibitor.HER2 insertion YVMA mutant lung cancer: Long natural history and response to afatinib.A novel acquired ALK F1245C mutation confers resistance to crizotinib in ALK-positive NSCLC but is sensitive to ceritinib.Problems of variable biomarker evaluation in stratified medicine research--A case study of ERCC1 in non-small-cell lung cancerThe race to target MET exon 14 skipping alterations in non-small cell lung cancer: The Why, the How, the Who, the Unknown, and the InevitableExpression of cyclin E and cyclin D1 in non-small cell lung cancersGenetic determinants of lung cancer short-term survival: the role of glutathione-related genesCyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and IIEffects of the ADH3, CYP2E1, and GSTP1 genetic polymorphisms on their expressions in Caucasian lung tissueAnticoagulant drugs increase natural killer cell activity in lung cancerHLA-F expression is a prognostic factor in patients with non-small-cell lung cancerOctreotide treatment for paraneoplastic intestinal pseudo-obstruction complicating SCLCPredictive significance of bone sialoprotein and osteopontin for bone metastases in resected Chinese non-small-cell lung cancer patients: a large cohort retrospective studylet-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosisAn electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controlsThe prognostic significance of ERCC1, BRCA1, XRCC1, and betaIII-tubulin expression in patients with non-small cell lung cancer treated by platinum- and taxane-based neoadjuvant chemotherapy and surgical resectionNovel effects of gefitinib on mucin production in bronchioloalveolar carcinoma; two case reportsGefitinib inhibits MUC5AC synthesis in mucin-secreting non-small cell lung cancer cellsThe anti-apoptotic livin gene is an important determinant for the apoptotic resistance of non-small cell lung cancer cellsMesothelin-related predictive and prognostic factors in malignant mesothelioma: a nested case-control study
P1433
Q22003821-D750B088-A1F0-4E8D-80B8-3EF318ED0E06Q22252372-1AAB8239-B11C-40C9-9B7D-682FB60B9651Q24312125-57A8AE4E-2E3E-4650-B4B4-531B32D4CDA3Q24315930-F3F1BB74-5C01-4649-9853-61E596C34F86Q24318465-6E1FABDF-B0FE-40A3-8E21-F6A8E698BF8CQ26781337-05D3B57D-F8C6-4F82-8135-B71A5CE48C28Q26997008-72FE7C1B-6FD9-4D93-9E45-E8DD50510CCCQ27000382-2C131A9E-C4E6-4B42-95D9-2961C1E3806DQ27023279-71782C8F-275A-4913-9540-B2E22B642660Q27024615-6ABA6442-3C6C-43EB-867C-ED80F740CC4DQ27851399-EB5E6E3B-C409-4BAB-A1A3-BF5C1CAFBB20Q27851463-E5F4440B-ECB0-47E1-A809-883AD2C99C31Q27851625-6DE58BF0-D948-4325-AD08-BCFD878FF269Q27851719-62C95622-41B6-44F0-9C2F-F91BB606E8CCQ27852395-5BFB82A3-3210-4507-93E0-3C9EF292D33AQ27852650-65DD2FB4-9378-457E-9FEB-410473D36DA0Q27852962-981A0503-70D7-4460-B15C-E812EB2C16D6Q27853098-61255198-EB11-429C-8243-3BD0293CA1A0Q27853123-A8B63487-8237-4972-A54D-EA95897FD2F4Q27853139-1643AFF7-6F3C-4469-9C83-C56B0EC1ED35Q27853240-8941BDCC-019A-4627-8C71-D8E912C766A4Q27853242-E2357D70-0B7C-48E8-97B4-4FF2F5C8C594Q27853321-666FDF76-1E86-44AF-95AE-E7CEABD40AEEQ28069810-18F48910-D2B9-4F5F-A717-AC3091E56113Q28076376-D4DCB865-F1C0-4920-8C1D-68AA86305B23Q28143370-30FBDBC1-3DD4-45BC-B066-6DB681654259Q28201239-D27072AA-66AD-4780-9130-FA25FFA43C26Q28202289-92862321-90A0-4FDA-B738-1F0B1C68141AQ28205610-2DFB4DAB-88DB-4507-8D2C-D5AEC2CD1A5CQ28212828-5290DF67-FAD7-4C8B-A448-3E79A43506B8Q28237305-249C772F-3B1C-4581-9A8A-BE02940797CEQ28240663-DD38514E-6145-4FC2-82EA-3BC2D516388FQ28241791-3DF832A9-96C4-44D2-A8D2-BF1F7CCFCF3EQ28242638-3501EECB-E78B-41EA-B553-DB1687481CB4Q28248282-CD9D6CA0-D472-4BA7-834C-35646D1B4AADQ28255211-0693C62A-5836-4CC9-A6A3-DBC31259CD37Q28255739-B40FFCDB-982F-45DC-A3F1-33BFC433514EQ28260981-DC399534-DF77-4DE9-8F44-36393395F98AQ28263015-8FDB25CD-8532-45BF-9EB3-5DB8C880DB2EQ28269021-3AF26E37-6FD8-4CBE-A652-5854246EB0BC
P1433
description
begutachtete wissenschaftliche Zeitschrift
@de
peer-reviewed scientific journal
@en
revista científica
@es
revue scientifique
@fr
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Elsevier
@nl
рецензований науковий журнал
@uk
वैज्ञानिक पत्रिका
@hi
name
Lung Cancer
@ast
Lung Cancer
@da
Lung Cancer
@de
Lung Cancer
@en
Lung Cancer
@es
Lung Cancer
@fi
Lung Cancer
@fr
Lung Cancer
@it
Lung Cancer
@nb
Lung Cancer
@nl
type
label
Lung Cancer
@ast
Lung Cancer
@da
Lung Cancer
@de
Lung Cancer
@en
Lung Cancer
@es
Lung Cancer
@fi
Lung Cancer
@fr
Lung Cancer
@it
Lung Cancer
@nb
Lung Cancer
@nl
prefLabel
Lung Cancer
@ast
Lung Cancer
@da
Lung Cancer
@de
Lung Cancer
@en
Lung Cancer
@es
Lung Cancer
@fi
Lung Cancer
@fr
Lung Cancer
@it
Lung Cancer
@nb
Lung Cancer
@nl
P31
P243
P3181
P4616
P1055
P1058
P1156
P1160
Lung Cancer
P123
P1277
P1476
Lung Cancer
@en
P236
P243
P3181
P407
P495
P571
1985-01-01T00:00:00Z